ArticleInternational journal of clinical pediatric dentistry2026
Comparative Evaluation of Clinical and Radiographic Success Rates of Direct Pulp Capping in Primary Molars Using TheraCal LC, 3Mixtatin, and Nanohydroxyapatite: An
Article in International journal of clinical pediatric dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: This Methods: Forty-five primary molars from children aged 3-9 years, exhibiting pinpoint pulp exposures (≤1 mm) with hemostasis achieved within 2-3 minutes, were randomly assigned ( Results: TheraCal LC showed 100% success at 3 and 6 months, slightly declining at 9 months (86.7% clinical, 93.3% radiographic). 3Mixtatin showed a steep drop to 53.3% clinical and 60% radiographic success at 9 months, with notable sinus tract formation and furcal radiolucency ( Conclusion: Nanohydroxyapatite exhibited the highest and most consistent success over the 9 months, outperforming both TheraCal LC and 3Mixtatin in sustaining pulp vitality. Clinical significance: The success of DPC in primary teeth is largely influenced by the use of materials with optimal biological compatibility. NHA demonstrated superior outcomes, offering effective pulp preservation and reducing the need for invasive treatments. How to cite this article: Borusu BP, Naren P, Martha S,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.